Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Acutus Medical, Inc. (AFIB)
|
Add to portfolio |
|
|
|
| Price: |
$3.54
| | Metrics |
| OS: |
29.3
|
M
| |
|
|
| Market cap: |
$104
|
M
| |
|
|
|
Net cash:
|
$19.9
|
M
| |
$0.68
|
per share
|
|
EV:
|
$83.7
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 16.4 | 17.3 | 8.5 | 2.8 | 69.3 | 47.8 |
| Revenue growth | -5.2% | 104.0% | 198.4% | -95.9% | 45.1% | |
| Cost of goods sold | 31.9 | 32.9 | 15.9 | 9.2 | 49.2 | 30.7 |
| Gross profit | -15.5 | -15.7 | -7.4 | -6.4 | 20.2 | 17.1 |
| Gross margin | -95.0% | -90.7% | -87.7% | -225.9% | 29.1% | 35.7% |
| Selling, general and administrative | 47.7 | 63.5 | 50.4 | 26.8 | 1,030.9 | 1,165.8 |
| Research and development | 28.2 | 36.7 | 33.5 | 23.0 | | |
| EBITA | -12.5 | -115.2 | -90.8 | -71.5 | -1,010.8 | -1,148.7 |
| EBITA margin | -76.5% | -667.5% | -1072.5% | -2522.3% | -1457.7% | -2404.1% |
| Amortization of intangibles | 0.4 | 0.6 | 0.5 | 0.3 | | |
| EBIT | -12.9 | -115.9 | -91.2 | -71.8 | -1,010.8 | -1,148.7 |
| EBIT margin | -79.1% | -671.2% | -1077.9% | -2531.1% | -1457.7% | -2404.1% |
| Pre-tax income | -39.5 | -117.7 | -102.0 | -97.0 | -1,141.8 | -1,179.0 |
| Income taxes | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | | 0.0% | 0.0% | 0.0% |
| Net income | -39.6 | -117.7 | -102.0 | -97.0 | -1,141.8 | -1,179.0 |
| Net margin | -242.1% | -681.8% | -1205.1% | -3421.7% | -1646.7% | -2467.5% |
| |
| Diluted EPS | ($1.40) | ($4.11) | ($8.94) | ($144.41) | | |
| Shares outstanding (diluted) | 28.3 | 28.7 | 11.4 | 0.7 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|